home / stock / staa / staa news


STAA News and Press, STAAR Surgical Company From 03/26/24

Stock Information

Company Name: STAAR Surgical Company
Stock Symbol: STAA
Market: NASDAQ
Website: staar.com

Menu

STAA STAA Quote STAA Short STAA News STAA Articles STAA Message Board
Get STAA Alerts

News, Short Squeeze, Breakout and More Instantly...

STAA - Nvidia's Market Cap Myopia: 3 Stocks Proving Size Isn't Everything

2024-03-26 11:45:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Nvidia (NASDAQ: NVDA ) is massive. It is the third-largest company by market capitalization. In a little more than one year, the artificial intelligence ( AI ) chipmaker gre...

STAA - STAAR Surgical Celebrates Three Million Implantable Collamer® Lenses

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today announced that more than three million ICLs have been sold globally. 1 This press re...

STAA - STAAR Surgical Company: Potential Buy After Long-Term Valuation Downgrade

2024-03-13 10:43:07 ET Summary STAAR Surgical Company's share price has experienced significant volatility, dropping over 60% in less than 9 months between 2022 and 2023. The company's 2023 earnings showed a 13% increase in net sales, however, with strong performance in China offs...

STAA - STAAR Surgical Adds Arthur Butcher and Wei Jiang to Board of Directors

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (ICL) for myopia, astigmatism and presbyopia, today announced the appointment of Arthur Butcher, Executive Vice President and Group President, MedSurg and A...

STAA - Underperform Recommendation Issued On STAA By Barclays

2024-03-11 09:30:03 ET Barclays analyst issues UNDERPERFORM recommendation for STAA on March 11, 2024 08:16AM ET. The previous analyst recommendation was Underperform. STAA was trading at $35.86 at issue of the analyst recommendation. The overall analyst consensus : BUY....

STAA - STAAR Surgical to Participate in Two Upcoming Investor Conferences

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today announced that management will participate in meetings with investors at the following confe...

STAA - STAAR Surgical Reports Fourth Quarter and Fiscal Year 2023 Results

Generates Double-Digit Sales Growth and Continuing Profitability ICL Sales Up 22% in Fourth Quarter and 18% in Fiscal 2023 Affirms Sales Outlook for Fiscal 2024 STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Imp...

STAA - Expected US Company Earnings on Monday, February 26th, 2024

SUIC Worldwide Holdings Ltd (SUIC) is expected to report for Q4 2023 QuantaSing Group Limited (QSG) is expected to report $0.11 for Q2 2024 uniQure N.V. (QURE) is expected to report $-1.54 for Q4 2023 Albany International Corporation (AIN) is expected to report $0.84 for Q4 2023 I...

STAA - Notable earnings after Monday's close

2024-02-25 17:35:04 ET Major earnings expected after the bell on Monday include: Zoom Video Communications ( ZM ) Unity Software ( U ) ONEOK ( OKE ) Innovative Industrial Properties ( IIPR ) Workday ( WDAY ) Read the full article on Seeking ...

STAA - STAAR Surgical Q4 2023 Earnings Preview

2024-02-23 17:35:15 ET More on STAAR Surgical STAAR Surgical: Slowly Coming In My Sight STAAR Surgical collaborates with SharpeVision in the U.S. STAAR Surgical forecasts 2024 net sales between $335M - $340M Seeking Alpha’s Quant Rating on STAAR Surgic...

Previous 10 Next 10